ALPS Active Equity Opportunity ETF (NYSEARCA:RFFC – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totaling 637 shares, a growth of 563.5% from the September 30th total of 96 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily volume of 1,054 shares, the days-to-cover ratio is currently 0.6 days.
Institutional Investors Weigh In On ALPS Active Equity Opportunity ETF
An institutional investor recently bought a new stake in ALPS Active Equity Opportunity ETF stock. Tenzing Financial LLC bought a new stake in ALPS Active Equity Opportunity ETF (NYSEARCA:RFFC – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,885 shares of the company’s stock, valued at approximately $218,000. Tenzing Financial LLC owned approximately 0.72% of ALPS Active Equity Opportunity ETF as of its most recent SEC filing.
ALPS Active Equity Opportunity ETF Price Performance
Shares of RFFC stock traded up $0.04 during mid-day trading on Tuesday, hitting $76.62. 487 shares of the stock traded hands, compared to its average volume of 1,016. The stock has a market cap of $30.65 million, a P/E ratio of 25.00 and a beta of 0.94. The stock’s fifty day moving average is $76.81 and its two-hundred day moving average is $72.92. ALPS Active Equity Opportunity ETF has a 52-week low of $64.05 and a 52-week high of $77.75.
ALPS Active Equity Opportunity ETF Company Profile
The RiverFront Dynamic US Flex-Cap ETF (RFFC) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively-managed fund of US stocks selected on the basis of multiple factors such as value, quality, and momentum. RFFC was launched on Jun 7, 2016 and is managed by RiverFront.
See Also
- Five stocks we like better than ALPS Active Equity Opportunity ETF
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
- Intel’s $155 Price Target Raises a Bigger Question About Its Turnaround Potential
Receive News & Ratings for ALPS Active Equity Opportunity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Active Equity Opportunity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
